Global Markets for Blood Plasma Products

Report Code: HLC201C

Publish Date: Mar 2023

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global blood plasma products market should reach $45.7 billion by 2027 from $33.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.6% for the forecast period of 2022 to 2027.

Report Includes

  • 44 data tables and 30 additional tables
  • An overview of the global market for blood plasma products
  • Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Characterization and quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
  • Detailed information related to mode of delivery for blood plasma
  • Analysis of key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
  • Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
  • In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
  • A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centres and rising disease awareness and education
  • Profiles of the major players in the industry, including ADMA Biologics Inc., China Biologic Products Inc., Kedrion SpA, Octapharma AG, and Takeda Pharmaceutical Co. Ltd.

Report Scope

This research report presents an in-depth analysis of the global blood plasma products market by product type, application, end user and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma.

The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. It also features an in-depth analysis of the key companies operating in the global blood plasma products market, and it surveys patents that highlight past, current and projected global technology trends. The blood plasma products market is primarily segmented into five major categories: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma products market is segmented into the following: hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.

In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the Rest of the World (RoW). Key regions like the U.S., Canada, Europe (U.K., Italy, France, Germany), China, India, Australia and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2021 as the base year and forecasting forward to 2027. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers’ total revenues.

A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market’s supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches and pipeline products are provided.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $31.4 billion
Market size forecast $45.7 billion
Growth rate CAGR of 6.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered product type, application, end-user and region
Regions covered North America, Asia-Pacific, Europe, and Rest of the World
Countries covered U.S., Canada, U.K., Germany, France, Italy, Rest of Europe, China, India, Japan, Australia, and Rest of APAC
Key Market Drivers
  • Increasing Demand for Immunoglobulins in Therapeutic Treatments
  • Rising Prevalence of Alpha-1 Antitrypsin Deficiency (AATD)
  • Increased Geriatric Population Worldwide
  • Increase in Blood Donations
  • Increasing Use of Recombinant Plasma and Non-Plasma Based Products in Therapeutic Treatments
  • High Costs Associated with Blood Plasma Products
  • Stringent Government Regulations and Low Reimbursement Policies
  • Growing Investments in Plasma Fractionation Capacities
  • Increasing Research on New Formulations and Indications
  • Rising Incidence of Hemophilia
  • Opportunities in Emerging Nations
Companies studied
ADMA BIOLOGICS INC.BAXTER INTERNATIONAL INC.
BIO PRODUCTS LABORATORY LTD.CHINA BIOLOGIC PRODUCTS INC.
CSL BEHRINGGRIFOLS INTERNATIONAL S.A.
INNOVATIVE RESEARCHINTAS PHARMACEUTICALS LTD.
KEDRION S.p.A.LFB S.A.
OCTAPHARMA AGSANQUIN
TAKEDA PHARMACEUTICAL CO. LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The blood plasma market is projected to grow from $31.4 billion in 2021 to $45.7 billion in 2027, at a compound annual growth rate (CAGR) of 6.6% during the forecast period.
The increasing demand for immunoglobulins in various therapies, the rising prevalence of Alpha-1 Antitrypsin Deficiency (AATD), and the increase in blood donations are responsible for market growth.
The blood plasma market is segmented on the product type, application, end-user and region.
Immunoglobulins segment will dominate the market by the end of 2027.
North America has the highest market share.
Grifols, Takeda, CSL, Kedrion, Octapharma, and LFB SA

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Blood Plasma Products144Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background14Free
Chapter- 4: Market Breakdown by Product Type19Free
Chapter- 5: Market Breakdown by Application13Free
Chapter- 6: Market Breakdown by End User7Free
Chapter- 7: Market Breakdown by Region30Free
Chapter- 8: Mode of Delivery for Blood Plasma Products7Free
Chapter- 9: Patent Review and Clinical Trial Landscape5Free
Chapter- 10: Impact of the COVID-19 Pandemic on the Market for Blood Plasma Products2Free
Chapter- 11: Competitive Landscape8Free
Chapter- 12: Company Profiles28Free
Published - Jan-2019| Analyst - BCC Publishing| Code - HLC201B

Report Highlights

The global blood plasma products market should reach $35.5 billion by 2023 from $25.7 billion in 2018 at a compound annual growth rate (CAGR) of 6.6% for the period 2018-2023.

Report Includes

  • 52 data tables and 24 additional tables
  • Industry analysis of the global market for blood plasma products
  • Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
  • Qualitative information related to mode of delivery for blood plasma
  • Key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
  • Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
  • In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
  • A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centers and rising disease awareness and education
  • Profiles of the major players in the industry, including ADMA Biologics Inc., Baxter International Inc., Creat Group, Octapharma AG, Shire Plc and TCS Biosciences Ltd.
Published - Jul-2017| Analyst - Yojana Jeevane| Code - HLC201A

Report Highlights

The global market for blood plasma reached $16.8 billion in 2016 and should reach $23.0 billion in 2021, growing at a compound annual growth rate (CAGR) of 6.6% from 2016 through 2021.

Report Includes

  • An overview of the global markets for blood plasma products.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Analysis of the market by product, application, mode of delivery and by end user.
  • Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products.
  • In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion.
  • A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centers and rising disease awareness and education.
  • Profiles of major players in the industry.

Related Reports

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - Feb 2024 | Publisher - Partha Sarathi Das | Code - BIO079E

The global market for biological therapeutic drugs is expected to increase from $452.9 billion in 2023 to $823.4 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.7% during the forecast period of 2023-2028.

Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

Published - Nov 2023 | Publisher - Bejini Sandeep Kumar | Code - PHM119C

The global market for antithrombotic/anticoagulant drugs is estimated to grow from $31.6 billion in 2023 to reach $46.2 billion by 2028, at a compound annual growth rate (CAGR) of 7.9% from 2023 through 2028.

Artificial Blood: Global Markets to 2028

Published - Sep 2023 | Publisher - BCC Publishing | Code - BIO164B

The global artificial blood market reached $23.9 million in 2022, should reach $26.1 million by 2023 and $40.5 million by 2028 with a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023-2028.

Immunoglobulins: Global Market Outlook

Published - Apr 2023 | Publisher - BCC Publishing | Code - BIO241A

The goal is to furnish an up-to-date analysis of the global immunoglobulins market and future opportunities in the market. The report provides an overview of the global immunoglobulins market and examines market trends. It also highlights major trends and challenges that affect the market and the vendor landscape. The scope of the study encompasses the current and forecast markets for normal and hyper immunoglobulins , includes market drivers and restraints, the competitive landscape, and current and emerging technologies. It also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.

Recent Reports

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Microelectromechanical Systems (MEMS) in Global Medical Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC129B

The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.

Medical Waste Management Market

Published - Jan 2024 | Publisher - BCC Publishing | Code - HLC297A

The report provides an overview of the global market for medical waste management and its related segment. The report has been segmented based on type, service, and region. Using 2022 as the base year, the report provides estimated market data for 2023 through 2028. The report covers merger and acquisition strategies, emerging trends, and future opportunities. It also covers the market share of major market players. It includes the company profiles of the major players, with brief information about their recent developments.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

Flame Retardant Chemicals: Technologies and Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - CHM014Q

The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2021

Published - Nov 2022 | Publisher - BCC Publishing | Code - PHM263A

This report discusses exhaustive coverage of the pharmaceutical industry and its competitive landscape in terms of major player market ranking and top pharmaceutical drugs. Company profiles of the top fifty pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well researched and analyzed in this report. The study include tracking alliances, joint ventures, mergers and acquisitions, new product development and R&D in the global pharmaceutical drugs market and the factors that will affect the industry in the coming years.

Pediatric Vaccines: Global Markets

Published - Oct 2022 | Publisher - BCC Publishing | Code - PHM265A

The global pediatric vaccines market should reach $34.5 billion by 2022 and more than $50.2 billion by 2027, with a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2022-2027.

Sustainable Plastic Packaging: Global Markets

Published - Oct 2022 | Publisher - BCC Publishing | Code - PLS122A

The global market for sustainable plastic packaging is estimated to increase from $90.0 billion in 2022 to reach $117.5 billion by 2027, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2022-2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Blood Plasma Products
Sample Report